HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hb Lepore-Leiden: a new delta/beta rearrangement associated with a beta-thalassemia minor phenotype.

Abstract
The Lepore hemoglobins (Hbs) are a group of structural defects resulting from different recombination events between the delta- and beta-globin genes. They may come with different beta-thalassemia (beta-thal) minor-like phenotypes in the carrier and with variably severe phenotypes in the rare homozygote, and in the common compound heterozygote with beta-thal. The most seriously affected patients are those of Yugoslavian origin presenting with severe transfusion-dependent hemolytic anemia, dyserythropoiesis, hepatosplenomegaly and skeletal malformations. Because of genetic risk, couples where both partners are carriers of these combinations may require prognosis and prenatal diagnosis. In these cases, recognition of the defect must be done with particular care. We report a case of Hb Lepore induced by a yet unknown crossover event found in a 24-year-old Turkish male and compare the novel mutation with those previously reported.
AuthorsCornelis L Harteveld, Pierre W Wijermans, Sandra G J Arkesteijn, Peter Van Delft, Jean-Louis Kerkhoffs, Piero C Giordano
JournalHemoglobin (Hemoglobin) Vol. 32 Issue 5 Pg. 446-53 ( 2008) ISSN: 1532-432X [Electronic] England
PMID18932069 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Hemoglobins, Abnormal
  • hemoglobin Leiden
  • Hemoglobin A2
  • hemoglobin Lepore
Topics
  • Amino Acid Sequence
  • Base Sequence
  • Hemoglobin A2 (genetics)
  • Hemoglobins, Abnormal (genetics)
  • Humans
  • Male
  • Young Adult
  • beta-Thalassemia (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: